Nuveen
SRTA

Nuveen’s Strata Critical Medical Inc SRTA Stock Holding History

Nuveen’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.75M Buy
332,890
+185,936
+127% +$978K ﹤0.01% 2639
2026
Q1 		$614K Buy
146,954
+962
+0.7% +$4.63K ﹤0.01% 2765
2025
Q4 		$702K Hold
145,992
– – ﹤0.01% 2754
2025
Q3 		$739K Hold
145,992
– – ﹤0.01% 2759
2025
Q2 		$588K Sell
145,992
-207,704
-59% -$676K ﹤0.01% 2825
2025
Q1 		$1.27M Sell
353,696
-727,484
-67% -$2.61M ﹤0.01% 2525
2024
Q4 		$4.6M Buy
1,081,180
+342,250
+46% +$1.3M ﹤0.01% 2026
2024
Q3 		$2.17M Buy
738,930
+485,430
+191% +$1.55M ﹤0.01% 2377
2024
Q2 		$882K Buy
253,500
+12,990
+5% +$43.3K ﹤0.01% 2777
2024
Q1 		$685K Buy
240,510
+74,800
+45% +$231K ﹤0.01% 2854
2023
Q4 		$585K Buy
165,710
+7,402
+5% +$21.2K ﹤0.01% 2952
2023
Q3 		$410K Sell
158,308
-1,529
-1% -$5.37K ﹤0.01% 2904
2023
Q2 		$630K Sell
159,837
-8,519
-5% -$27K ﹤0.01% 2854
2023
Q1 		$569K Sell
168,356
-17,116
-9% -$69.8K ﹤0.01% 2775
2022
Q4 		$664K Sell
185,472
-21,601
-10% -$92.3K ﹤0.01% 2814
2022
Q3 		$834K Sell
207,073
-5,314
-3% -$27.3K ﹤0.01% 2824
2022
Q2 		$947K Buy
+212,387
New +$1.53M ﹤0.01% 2803

Other funds holding SRTA

TP
Third Point New York $4.68B AUM 37.3% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $337M AUM 63.03% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
PLC
Pillsbury Lake Capital San Francisco, California $366M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen's SRTA Position: Q2 2026 in Review

Nuveen increased its Strata Critical Medical Inc (SRTA) stake by 127% in Q2 2026, buying an estimated $978K and bringing the position to 332,890 shares worth $1.75M. The position accounts for ﹤0.01% of the portfolio, ranked #2639.

Nuveen first reported a position in SRTA in Q2 2022 and has held it in 17 quarters since. The position peaked at $4.6M in Q4 2024. 140 funds tracked by Wall St. Rank hold SRTA as of Q2 2026.

  • Nuveen held 332,890 shares of Strata Critical Medical Inc worth $1.75M as of Q2 2026.
  • Nuveen bought 185,936 Strata Critical Medical Inc shares in Q2 2026, an estimated $978K.
  • Strata Critical Medical Inc made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #2639 holding.
  • Nuveen first reported a position in Strata Critical Medical Inc in Q2 2022 and has held it in 17 quarters since.
  • Nuveen's Strata Critical Medical Inc position peaked at $4.6M in Q4 2024.
  • 140 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.